Notes / Company

Kilitch Drugs (India) Ltd.

KILITCH BSE 524500 ISIN INE729D01010 Pharmaceuticals

Fundamentals

Market cap: ₹643 cr
P/E: 21.31×
ROE: 13.20%
Debt / equity: 0.24
52-week range: 121.10 — 245.00

Research on Tijori Finance

Company snapshot

Kilitch Drugs (India) Ltd.

Pharmaceuticals

₹643 cr

P/E 21.31×

Latest quarter · Mar 2026

Sales₹90 cr

Net profit₹15 cr

Op. margin+24.7%

EPS₹4.15

Strength & growth

Debt / equity0.24×

Current ratio2.06×

Sales CAGR+27.3%

EPS CAGR+18.9%

The timeline — 1 note on Kilitch Drugs (India) Ltd.

June 2026

17 Jun 26 · 2:14 PM IST Brief

Brief · Micro cap

Kilitch Drugs starts nutraceutical block, no revenue numbers

New manufacturing block begins at greenfield facility but capacity and investment undisclosed.

Verify on exchange BSE filings for KILITCH NSE filings for KILITCH Tijori Finance company page